Treatment of stimulant use disorder: a systematic review of reviews
Aims Stimulant use disorder contributes to a substantial worldwide burden of disease,
although evidence-based treatment options are limited. This systematic review of reviews …
although evidence-based treatment options are limited. This systematic review of reviews …
[HTML][HTML] Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: potential therapeutic impacts
Methamphetamine (METH) use, and misuse are associated with severe socioeconomic
consequences. METH users develop tolerance, lose control over drug taking behaviors, and …
consequences. METH users develop tolerance, lose control over drug taking behaviors, and …
Bupropion and naltrexone in methamphetamine use disorder
MH Trivedi, R Walker, W Ling… - … England Journal of …, 2021 - Mass Medical Soc
Background The use of naltrexone plus bupropion to treat methamphetamine use disorder
has not been well studied. Methods We conducted this multisite, double-blind, two-stage …
has not been well studied. Methods We conducted this multisite, double-blind, two-stage …
Pharmacological treatments for methamphetamine addiction: current status and future directions
J Ballester, G Valentine, M Sofuoglu - Expert review of clinical …, 2017 - Taylor & Francis
Introduction: Methamphetamine (MA) abuse remains a global health challenge despite
intense research interest in the development of pharmacological treatments. This review …
intense research interest in the development of pharmacological treatments. This review …
Pharmacotherapeutic agents in the treatment of methamphetamine dependence
KC Morley, JL Cornish, A Faingold… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Methamphetamine use is a serious public health concern in many countries
and is second to cannabis as the most widely abused illicit drug in the world. Effective …
and is second to cannabis as the most widely abused illicit drug in the world. Effective …
Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine
Abstract The Addictions Neuroclinical Assessment (ANA) was proposed as a neuroscience-
informed clinical framework to understand heterogeneity in addiction encompassing …
informed clinical framework to understand heterogeneity in addiction encompassing …
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
S Mediouni, MC Garibaldi Marcondes, C Miller… - Frontiers in …, 2015 - frontiersin.org
Antiretroviral therapy has dramatically improved the lives of human immunodeficiency virus
1 (HIV-1) infected individuals. Nonetheless, HIV-associated neurocognitive disorders …
1 (HIV-1) infected individuals. Nonetheless, HIV-associated neurocognitive disorders …
Endogenous opiates and behavior: 2015
RJ Bodnar - Peptides, 2017 - Elsevier
This paper is the thirty-eighth consecutive installment of the annual review of research
concerning the endogenous opioid system. It summarizes papers published during 2015 …
concerning the endogenous opioid system. It summarizes papers published during 2015 …
Evidence-based guidelines for the pharmacologic management of methamphetamine dependence, relapse prevention, chronic methamphetamine-related, and …
R Härtel-Petri, A Krampe-Scheidler… - …, 2017 - thieme-connect.com
The increasing abuse of the street drug crystal meth (methamphetamine) in many countries
worldwide has resulted in a growing demand to treat patients who have acquired a …
worldwide has resulted in a growing demand to treat patients who have acquired a …
Neurobiology of craving: current findings and new directions
Abstract Purpose of the Review This review seeks to provide an update on the current
literature on craving and its underlying neurobiology, as it pertains to alcohol and drug …
literature on craving and its underlying neurobiology, as it pertains to alcohol and drug …